Skip to main content
OpenTrials
Completed

NCT Number: NCT05876689

Swept Source OCT Imaging With the DREAM VG-OCT

The Intalight Dream OCT is the first combo anterior plus posterior device to perform both OCT and OCT-A at depth of 16mm. This is especially useful in patient who are very nearsighted as it allows us to image all in one frame. The intention of this study is to see how the images differ on the same patients when compared to the Cirrus OCT and to test for the repeatability of the images on a single day.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Eye Diseases Glaucoma Myopia Ocular Hypertension Refractive Errors

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Byers Eye Institute

Palo Alto, California, 94303, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age greater than or equal to 18
  • Myopes with a current or previously documented spherical equivalent refraction < -4D
  • At least half of the subjects should have had at least one Cirrus OCT RNFL and macula performed as well as a Humphrey visual field performed in those with OCT abnormalities

Exclusion criteria

  • Unable to comply with study imaging
  • unclear ocular media
  • Participant has, in the opinion of the investigator, any physical or mental condition that would affect the participation in the study or may interfere with the study procedures, evaluations and outcome assessments.

Treatment and study plan

DREAM OCT

Device

Swept Source OCT (similar to Zeiss Plex Elite)

Primary outcomes

  1. Assessing difference in intraocular structures

    Time frame: Baseline

    Assessing the performance of the DREAM VG OCT scan patterns in high myopes including glaucomatous eyes to see if there are differences in the lamina cribrosa structure when compared to patients previous Cirrus OCTs.

  2. Assessing difference in intraocular vascular structures

    Time frame: Baseline

    Assessing differences in vascular density in areas with presumed myopic-related field defects vs. low tension glaucoma perimetric disease

Secondary outcomes

  1. Assessing repeatability of scans

    Time frame: Baseline

    Analyze the repeatability of quantitative RNFL and GCC parameters.

Sponsors and collaborators

Lead sponsor

Robert T. Chang, MD

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
May 25, 2023
Registry last updated
Nov 25, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.